Quantinno Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113M Buy
292,027
+95,658
+49% +$35.5M 0.14% 133
2026
Q1
$57.5M Buy
196,369
+115,886
+144% +$38.1M 0.1% 236
2025
Q4
$28.2M Buy
80,483
+23,785
+42% +$8.04M 0.06% 398
2025
Q3
$18.3M Buy
56,698
+12,787
+29% +$3.98M 0.05% 429
2025
Q2
$17.1M Buy
43,911
+23,180
+112% +$9.32M 0.07% 311
2025
Q1
$9.02M Buy
20,731
+12,211
+143% +$4.9M 0.06% 404
2024
Q4
$3.14M Sell
8,520
-3,369
-28% -$1.41M 0.03% 663
2024
Q3
$6.18M Buy
11,889
+2,461
+26% +$1.31M 0.08% 273
2024
Q2
$5.11M Buy
9,428
+2,813
+43% +$1.49M 0.09% 225
2024
Q1
$3.43M Buy
6,615
+1,051
+19% +$523K 0.07% 313
2023
Q4
$2.62M Buy
5,564
+1,263
+29% +$584K 0.09% 278
2023
Q3
$1.87M Buy
4,301
+586
+16% +$266K 0.09% 313
2023
Q2
$1.65M Sell
3,715
-2,233
-38% -$1.03M 0.09% 270
2023
Q1
$2.73M Buy
5,948
+278
+5% +$132K 0.18% 108
2022
Q4
$2.91M Buy
5,670
+2,517
+80% +$1.28M 0.22% 98
2022
Q3
$1.43M Buy
3,153
+1,641
+109% +$785K 0.18% 137
2022
Q2
$730K Buy
1,512
+899
+147% +$445K 0.11% 248
2022
Q1
$301K Buy
613
+124
+25% +$56.7K 0.05% 437
2021
Q4
$227K Buy
+489
New +$206K 0.04% 467
2021
Q1
Sell
-821
Closed -$264K 273
2020
Q4
$264K Sell
821
-1,603
-66% -$492K 0.2% 264
2020
Q3
$651K Buy
2,424
+1,587
+190% +$427K 0.44% 5
2020
Q2
$220K Buy
+837
New +$223K 0.22% 261
2019
Q2
Sell
-802
Closed -$230K 452
2019
Q1
$230K Buy
+802
New +$232K 0.15% 319

Other funds holding ELV

Quantinno Capital Management's ELV Position: Q2 2026 in Review

Quantinno Capital Management increased its Elevance Health (ELV) stake by 49% in Q2 2026, buying an estimated $35.5M and bringing the position to 292,027 shares worth $113M. The position accounts for 0.14% of the portfolio, ranked #133.

Quantinno Capital Management first reported a position in ELV in Q1 2019 and has held it in 23 quarters since. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Quantinno Capital Management held 292,027 shares of Elevance Health worth $113M as of Q2 2026.
  • Quantinno Capital Management bought 95,658 Elevance Health shares in Q2 2026, an estimated $35.5M.
  • Elevance Health made up 0.14% of Quantinno Capital Management's portfolio in Q2 2026, its #133 holding.
  • Quantinno Capital Management first reported a position in Elevance Health in Q1 2019 and has held it in 23 quarters since.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.